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Abstract
Background: There are few comprehensive reviews of breast cancer outcomes in older women.
We synthesize data to describe key findings and gaps in knowledge about the outcomes of breast
cancer in this population.
Methods: We reviewed research published between 1995 and June 2003 on breast cancer quality
of life and outcomes among women aged 65 and older treated for breast cancer. Outcomes
included communication, satisfaction, and multiple quality of life domains.
Results: Few randomized trials or cohort studies that measured quality of life after treatment
focused exclusively on older women. Studies from older women generally noted that, with the
exception of axillary dissection, type of surgical treatment generally had no effect on long-term
outcomes. In contrast, the processes of care, such as choosing therapy, good patient-physician
communication, receiving treatment concordant with preferences about body image, and low
perceptions of bias, were associated with better quality of life and satisfaction.
Conclusions: With the exception of axillary dissection, the processes of care, and not the therapy
itself, seem to be the most important determinants of long-term quality of life in older women.
Introduction
Breast cancer is an important disease and one where
health care services have the potential to improve the
quality and quantity of life. Breast cancer is also largely a
disease of old age [1,2]. By the year 2030, one in five
women in the United States will be 65 years of age or
older (hereinafter referred to as "older") [3]. This demo-
graphic imperative, coupled with the dramatic increases
in rates of breast cancer with advancing age, is expected to
translate into a large absolute increase in the number of
older women treated for and surviving breast cancer [4].
These older breast cancer survivors are likely to be a phys-
iologically, socially, and racially heterogeneous group
with varying numbers of comorbid conditions and vary-
ing outcomes following treatment for their disease [4,5].
Older women diagnosed with breast cancer today have
many different treatment options from which to choose.
While most women will chose treatments that maximize
survival, information about quality of life can be an
important component in decision-making in several clin-
ical situations. For instance, if a woman is considering two
treatments with equivalent survival, such as mastectomy
and breast conservation, then quality of life outcomes
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may be important considerations in her treatment deci-
sion-making. Likewise, in clinical trials of equivalent
approaches, quality of life may be the identifying factor in
determining the most "effective" treatment. Quality of life
may also be important to women, providers, and
researchers comparing the overall benefits of very toxic,
but very effective regimens with those of less toxic
approaches that yield somewhat lower survival. The bal-
ance of effectiveness, harms, and quality of life is espe-
cially important for older women, since treatment
decisions must also factor in interactions of comorbid
conditions and treatment.
Unfortunately, until recently, older women were not
included in sizable numbers in breast cancer research. In
addition, the inclusion of quality of outcomes into clini-
cal and observation trials is also a fairly recent trend [6].
Thus, there is only limited information available on qual-
ity of life outcomes after different treatment regimens
among diverse older populations. In this paper we review
what is known about quality of life outcomes in older
women with breast cancer. We highlight findings across
multiple domains, discuss special considerations in meas-
uring outcomes in this age group, and make some recom-
mendations for future research. This review is intended to
serve as a focal point for discussion and extension of exist-
ing efforts to improve the quality of breast cancer care for
the growing older population.
Methods
For the purposes of this review, quality of life outcomes
associated with breast cancer care are defined as the net
effects of the health care structure and process on the
health and well-being of women diagnosed with this dis-
ease [7]. As such, quality of life is a multidimensional con-
struct encompassing clinical, financial, functional, and
psychosocial domains affected by treatment and its inter-
actions with baseline comorbidity and circumstances
(Figure 1) [6–9]. We use the term quality of life to be syn-
onymous with the expression 'health-related quality of
life' [10].
To identify relevant articles for this review, we conducted
a search of published literature indexed on MedLine, Can-
cerLit, CINAHL, and PsychInfo between 1995 and June
2003. We chose 1995 as the earliest year for review to
ensure that results would be consistent with current stand-
ards of care. To capture literature encompassing a broad
set of domains that might be affected by breast cancer or
its treatments, we included the following terms in our
searches: "breast neoplasms" and "aged" or "elderly" with
"quality of life," "pain," "fatigue," "mental health,"
"adjustment," "body image," "satisfaction," "sexuality,"
"social support," "function," "communication," "cogni-
tion," or "economics." We also examined the bibliogra-
phies of retrieved articles for additional relevant citations.
For citations of articles published prior to 1995, we only
included sentinel articles pertinent to older women. We
confined our review to original reports of randomized tri-
als and cohort studies to examine data by age group and
domain of quality of life. We excluded methodological
articles, reviews, case series, and case reports, and non-
English language articles. Articles were reviewed for inclu-
sion of older women and data were abstracted on post-
treatment quality of life or other outcomes for this age
group. It should be noted that most observational studies
to date have only examined short-term side effects and
symptoms of treatment and future research is need on
long-term side effects of treatments in older breast cancer
survivors. We confine citations of data to results that were
statistically significant, highlighting findings that are con-
trolled for key confounding variables, such as baseline
functioning [11]. We present a qualitative summary of
these results. We did not attempt to conduct a meta-anal-
ysis of results since each study was conducted using vary-
ing time horizons, used different measurement tools and
definitions of quality of life domains, included heteroge-
neous populations with a variety of tumor stages, and was
conducted in different countries and cultural perspectives.
Results
Overall, few randomized trials or cohort studies measured
quality of life after treatment and focused exclusively on
older women [12–14]. With rare exceptions, [15–17]
studies involving breast cancer outcomes were conducted
in non-minority populations.
Processes of Care and Satisfaction
Satisfaction with breast cancer treatment is primarily a
function of the process of care, and not the actual treat-
ment received. A summary of these processes of care issues
is found in Table 1. As one example, women who felt their
surgeons initiated a conversation about treatment con-
cerns reported higher satisfaction six months post-treat-
ment than women who felt their surgeons communicated
less, controlling for treatment and other factors [18]. Of
note, surgeons who received additional training in surgi-
cal oncology have been noted by their older patients to
bring up a discussion about patient concerns 60% more
often (95% CI 1.02–2.56) than surgeons without spe-
cialty training [18].
Older patients may prefer and rely on physician-initiated
quality of life discussions [19] and may prefer that their
physicians provide information in person as opposed to
written materials [20]. Higher levels of communication,
both physician and patient-initiated, also affect women's
perceptions of having a choice of treatment. For instance,
in one study, older women who reported that their physi-
cians asked them caring questions, asked about their con-Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/45
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cerns, or who discussed a number of options were more
than twice as likely to report that they felt they were given
a choice of treatment, controlling for other factors [18].
Interestingly, there appears to be a positive health benefit
to having had a choice per se. In one cohort, by six
months after surgery, women who reported having had a
choice of therapy also reported higher adjusted global
Conceptual Model of Quality of Life in Older Breast Cancer Patients Figure 1
Conceptual Model of Quality of Life in Older Breast Cancer Patients
Table 1: Key issues in processes of care in older breast cancer patients
Issue Comment
Communication • Physician-initiated communication and shared-decision making related to increased satisfaction
• Increased communication related to increased perception of choice
Perceptions of ageism • Higher levels of perceived ageism related to decreased satisfaction with care
• Higher levels of perceived ageism related to higher levels of self-reported pain
Setting of care • In-patient rehabilitation or case management may improve outcomes in women with multiple comorbidities
Social support • Inadequate social support associated with less satisfaction with care
Preferences for treatment • Concordance between preference for appearance and type of surgical treatment related to better mental 
health
Adapted (in part) from Buchner and Wagner, 1992[98] and Mandelblatt, Bierman,et al. 1999[5]
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health on a linear rating scale than women who felt they
had no choice (78.7 vs. 75.3 on a zero to 100 scale, p =
.03) [21]. Women reporting a choice also felt more satis-
fied with their treatments than women who reported hav-
ing no choice, considering other factors. Other
investigators have also noted that women who share in
the decision-making process are more likely to report
being satisfied, have better post-treatment adjustment to
cancer, than women who feel that they did not participate
[9,22–25]. Of note, in one longitudinal cohort, older
women who received treatment that was consistent with
their preferences around body image reported better men-
tal health at follow-up than those who received surgery
that was inconsistent with their preferences (e.g., receiving
mastectomy without reconstruction despite a concern
about maintaining body image) [26]. Interventions to
facilitate decision-making that is consistent with prefer-
ences, such as CD-ROM programs, appear to have the
potential to improve satisfaction with treatment decisions
and with interactions with health care providers, as well as
increase overall self-reported health and physical func-
tioning [27].
Other features of women's interactions with the medical
care system appear to be significant predictors of satisfac-
tion, including perceptions of ageism (p = .01) and racism
p = .03) [16]. For example, women who perceive high lev-
els of ageism have reported less general satisfaction with
their breast cancer care than women who felt there was
less ageism in their interactions in the health care system.
The setting of care may also influence outcomes. For
instance, for older women with multiple comorbid ill-
nesses (>3), in-patient rehabilitation has been noted to
improve multiple domains of quality of life, and many of
these effects appeared to be maintained after discharge
[28]. Similarly, intensive nurse case management pro-
grams have been found to improve mood and reduce feel-
ings of uncertainty [29].
Experiences outside of the health care system, such as hav-
ing less social support, have also been associated with
being less satisfied with one's breast cancer care [13]. In
addition, Silliman and colleagues found that older
women with inadequate social support had poor psycho-
social outcomes after breast cancer treatment [30].
Preferences for Treatment
In the studies conducted to date, older patients are able to
state their preferences, and generally want to be fully
informed about their treatment options [31–34]. Prefer-
ences are important considerations in treatment choices
[35]. For example, in two studies, older breast cancer
patients were willing to select a risky treatment option
(chemotherapy with major toxicity) for a small increase in
life expectancy (e.g., 6 months) [31,36]. In another study,
80% of older women indicated that chemotherapy would
be worthwhile if they could live an additional two
years,[37] but others have found that women in this age
group would accept aggressive chemotherapy for as little
as a 1% increase in survival [38,39]. Overall, these results
suggest that older women are willing to trade-off short-
term physical well-being, such as occurs with chemother-
apy, for increased survival.
Physical Function and Pain
While many have hypothesized that breast conservation
will result in better post-treatment functioning than mas-
tectomy, in reviewing the literature we found that
adjusted physical function scores were not significantly
different by treatment group, [12] but rather, largely
related to women's general pre-morbid level of illness
[16,17,40–43].
The physical function outcome of treatment relates to use
of axillary node dissection [44]. In one series, the cumula-
tive risk of having arm problems two years post-treatment
were three times higher (95% CI 1.94–4.67) among
women who underwent axillary surgery compared to
women without axillary surgery, controlling for covari-
ates. Arm problems after axillary dissection were reported
by up to 60% of women and had a consistent negative
impact on long-term functional abilities [16]. Of note,
one study reported that the effects of having axillary dis-
section and arthritis were multiplicative two years post-
surgery (Figure 2) [45]. The expected benefit of having
fewer concerns about recurrence after axillary dissection
has not been demonstrated [16]. Using a decision analytic
approach, Parmigiani and colleagues also noted that axil-
lary dissection had an overall negative impact on the qual-
ity-adjusted survival of 60-year-old women [46]. Other
researchers have noted that long-term decrements in
physical function can affect activities of daily living that
are critical to an older woman's ability to live independ-
ently [42,43]. Thus, in a Medicare population, the risks of
axillary surgery may outweigh any benefits in guiding
adjuvant therapy or of more detailed knowledge of prog-
nosis [47–56]. Sentinel node biopsy has been shown to
have lower mordibity than axillary dissection, [57] and
may be particularly useful in older patients, especially
those with arthritis or other pre-existing mobility limita-
tions [58]. Final conclusions about the value of axillary
dissection will rest on the accuracy of sentinel biopsy and
women's preferences.
Radiation has not been found to increase pain or affect
quality of life (measured on the EORTC breast module) in
older women participating in clinical trials [14]. For older
women undergoing chemotherapy, quality-adjusted ben-
efits are similar to those seen in younger women whenHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/45
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considering women with estrogen receptor negative
tumors. For older women with estrogen positive disease,
quality adjusted survival is significantly improved with
chemotherapy, albeit at a somewhat lower level than seen
in younger women [59].
The process of care also seems to affect physical outcomes.
For instance, Mandelblatt and colleagues found that older
women who perceived high levels of ageism (vs. lower
levels) in the health care system or felt that they had no
choice of treatment (vs. having a choice) reported signifi-
cantly more bodily pain [13].
Symptoms
Symptoms, such as hot flashes on tamoxifen treatment,
have been noted to decrease general quality of life in older
women, either directly, or through associated disturbed
sleep and fatigue [60]. Fatigue from treatment, especially
in association with pain or other symptoms, can increase
anxiety and depression [61]. In a cross-sectional study of
841 older patients, pain, fatigue, and insomnia were sig-
nificantly related to losses in physical functioning, even
after controlling for cancer treatment and comorbid con-
ditions [62]. In a one-year follow-up of the same cohort,
chemotherapy was related to reports of fatigue in the
short-term, but not at one-year post-treatment [63]. A
recent randomized controlled trial of exercise training[64]
suggests that overall quality of life, as measured by the
FACT-B scale, increases significantly in the postmenopau-
sal breast cancer survivors who exercise regularly. Reduc-
tions in fatigue and improvements in mood were also
reported, indicating that further testing of exercise inter-
ventions in older breast cancer survivors is warranted.
Percent of older women reporting arm problems after axillary dissection: Relationship to presence of arthritis Figure 2
Percent of older women reporting arm problems after axillary dissection: Relationship to presence of arthritis.
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Mental Health and Overall Impact
The processes of care, including feeling like one had a
choice of treatment also are important predictors of
health outcomes. For example, in one cohort of older
women, choice was independently associated with reports
of better mental health [13]. Recently, Keating and col-
leagues extended these results and demonstrated that the
concordance between desired and actual decision-making
was actually more important than the actual process itself
[65].
Receipt of chemotherapy (yes vs. no) has not been related
to any long-term mental health outcomes except for hav-
ing a perception that breast cancer had a greater impact on
one's life, even after considering stage and other factors
[13]. One aspect of this negative impact has been distress
about weight gain associated with chemotherapy [66].
Interestingly, better educated women report that breast
cancer has a greater impact on their lives than their less
well educated counterparts, but the oldest women (75+
years) rate breast cancer as having less of an impact on
their lives than younger women (67 to 74 years) [13]. The
experience of having breast cancer has also been noted to
have positive effects on women's lives, [67]and feeling a
sense of purpose in life has been found to have a greater
impact on quality of life than breast cancer itself [67].
Interestingly, older women are less likely to use mental
health (or alternative medicine) services than younger
patients [68]. However, participation in mental health
support, such as performing expressive journaling has
been found to improve short-term (i.e., 3 months) mental
health outcomes and vitality and to decrease the number
of medical appointments for cancer-related symptoms
[69].
Cognition
Patients with breast cancer frequently complain of prob-
lems with their memory and concentration. Such reports
are known colloquially as "chemobrain" or "chemofog"
http://www.pinkribbon.com/chemobr.htm. Empirical
evidence is accumulating that cognitive problems are
associated with use of surgery and chemotherapy (e.g.,
Ahles et al, 2002) [70]. For example, Cimprich [71] exam-
ined attention and reported decrements in attention-
related tasks in older, but not in younger breast cancer
patients. Tamoxifen has also been found to negatively
affect cognition [72] in a sample of women aged 57–75.
As cognitive problems interact with fatigue, pain, depres-
sion, and sleep quality in their impact on functioning,
interventions to improve cognition (and/or reduce these
other symptoms) could lead to improvements in other
domains. Cognitive behavior therapy has been found to
be effective in improving sleep, cognition, and quality of
life in younger groups [73] and such interventions could
be expanded to include older women. Examination of
long-term cognitive effects of adjuvant treatment using
validated neuropsychological batteries and evaluation of
fatigue prior to and after surgery and adjuvant therapy is
warranted. Improving cognition may also have long-term
effects on survival, since impaired cognitive status has
been associated with poorer survival, controlling for age,
stage, and treatment [41].
Body Image and Sexuality
In the multi-center EORTC trial of mastectomy versus
breast conservation (plus tamoxifen) there was a trend
towards better body image one year after treatment
among women 70 years and older [12]. In other studies,
older women undergoing breast conservation have
reported better body image (and mental health) two-years
post-treatment compared to the women who had under-
gone mastectomy, [26,74] although results have been
inconsistent [75,76]. National estimates of breast recon-
struction rates following mastectomy demonstrate lower
use among older women, with only 1.3% to 4.1% of
women over age 70 having reconstruction compared to
17.9% of younger women [77,78].
There is a paucity of data on sexual feelings and outcomes
in older women with breast cancer. In our own research,
we observed that 15.1% of women had been sexually
active prior to breast cancer diagnosis and that many
women reported that breast cancer had either a "very neg-
ative" or "somewhat negative" impact on their sexual feel-
ings and interest (Mandelblatt, unpublished data, 2003).
Social and Role Function
Social and role functions are inextricably linked to social
support and integration prior to breast cancer diagnosis.
Breast cancer survivors who are more socially integrated
before their breast cancers report better post-treatment
role function and vitality than less socially integrated
women [79]. In fact, Michael and colleagues report that
social integration accounts for greater variance in quality
of life than treatment itself [79]. As a result, others have
developed social support interventions targeted to breast
cancer survivors with poor support systems. In a recent
randomized, prospective trial, the quality of life of older
women improved when communicating with a commu-
nity-based nurse case manager who provided help with
managing comorbid conditions, assistance with activities
of daily living (ADLs), and help navigating the health care
system [80]. Similarly, Silliman and colleagues [30] found
that older women relied heavily on their physicians for
support and they suggest enhanced physician-patient
communication may improve emotional health out-
comes in these women. With intense support, womenHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/45
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generally report better well-being and lower distress, [81]
although some studies have not been able to demonstrate
this effect [82].
Economic Outcomes
Breast cancer accounted for between one-fifth and one-
quarter of the $157 billion dollars in cancer costs in the
United States in 2001 [83]. Lower costs per woman have
been reported for older women compared to costs for
younger women[84]and is probably partly explained by
less aggressive treatment offered to older women [35].
Interestingly, economic market forces affect costs and pat-
terns of care in older women. For example, Hadley and
colleagues examined Medicare claims and demonstrated
that women living in areas with the highest ratio of mas-
tectomy fees relative to breast conservation fees were sig-
nificantly more likely to have mastectomy, while women
in areas where there was less of a fee differential between
the two procedures were most likely to get breast conser-
vation [85].
In one economic analysis spanning a five year horizon
after breast cancer treatment, Polsky and colleagues found
that the initial costs of six weeks of radiation makes breast
conservation more expensive than mastectomy, with no
significant differences in quality-adjusted survival. Sum-
ming costs and outcomes over five years post-treatment,
breast conservation and radiation cost more than
$200,000 per quality adjusted life year saved (QALY)
compared to mastectomy. In an alternative formulation,
where breast conservation and radiation are compared to
open choice, and choice is assumed to have a utility in and
of itself (as noted above), the cost-effectiveness ratio for
breast conservation drops to as low as approximately
$50,000 to $75,000 per QALY, well within the threshold
for current medical expenditures [86].
Caregiver Burden
There is a paucity of data about the impact of breast cancer
in older women on their family members and caregivers.
Female gender, older age, and past grief experiences have
been associated with increased distress and grief in
spousal caregivers of cancer patients [87]. In one study,
daughters and sisters of women with breast cancer per-
ceived that their information and support needs were not
well met [88]. In another report, Northouse and col-
leagues found that family members of patients with recur-
rent disease experienced decrements in emotional well
being, and that negative impact was mediated by family
hardiness and social support [89]. Among caregivers of a
small sample of cancer patients sleep problems predicted
63.6% of the variance in caregiver depression [90]. Since
older women are likely to be primary caregivers for their
spouses or grandchildren, when they are undergoing
breast cancer treatment or terminally ill, caregiver burden
is compounded by loss of this key family resource. Over-
all, more research is needed to assess caregiver needs and
develop appropriate interventions geared to older patients
and their families.
Special Considerations in Quality of Life Measurement
To date, quality of life assessments in older women have
employed a wide variety of methods and tools to assess
outcome. Some limitations of prior evaluations include
use of a limited number of domains, lack of standard
agreement on the appropriate comparison groups (e.g.,
other cancer patients, women without cancer) or failure to
compare results to any control group, and inclusion of
narrow segments of the breast cancer population (e.g.,
only well-educated, non-minority women). Furthermore,
few prior studies were designed to specifically evaluate
outcomes for older women, particularly to assess the
interactions of decrements in function or well being asso-
ciated with treatment with comorbid conditions. For
example, mild treatment related peripheral neuropathy
might significantly impair ambulation in an older dia-
betic woman with pre-existing neuropathic changes. Vis-
ual problems associated with tamoxifen could be
especially detrimental to older women with underlying
visual impairment. Lack of control for baseline function
may also over-estimate the magnitude of treatment-
related decrements in quality of life.
Certain domains of quality of life may be more salient to
older women than other groups of breast cancer patients.
For instance, for older women, ambulation and mobility
impairments may make the difference between independ-
ent living and assisted living [43,91]. Likewise, mild
fatigue may have a multiplicative effect in impairing activ-
ities of daily living in a frail older woman, while only
being bothersome to a younger woman. Presence of
comorbid conditions may also limit discussion of treat-
ment options [92] or complicate delivery of treatment
such as chemotherapy [40,93,94]. Conversely, it is impor-
tant to recognize heterogeneity in elderly women such
that special subsets will have few chronic diseases and
greater functional status; such patients will be able to tol-
erate more intensive therapy (i.e. "fit elderly") [95].
Administration of quality of life evaluations for older
patients may also be difficult and can compromise the
quality of data obtained. For instance, visual or hearing
problems may lead to miscomprehension of survey items,
and memory impairments may lead to obtaining inaccu-
rate data, especially about more distal events. Older
women also may telescope time and discount the impor-
tance of health events that are in the future versus those in
the present.Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/45
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Thus, as indicated by the pathways depicted in Figure 1,
consideration of comorbidity data is essential for future
outcomes research among older women. Exclusion of
older women with multiple comorbidities from clinical
trials may result in less representative samples of breast
cancer patients and interfere with improving understand-
ing of the impact that such conditions have on quality of
life. Specialized tools and methodologies may need to be
developed and applied to research with older female pop-
ulations to fully capture non-cancer influences on out-
comes. Examples could include the multiple informants
approach when working with cognitively impaired
women [96] or the Comprehensive Prognostic Index [97]
which is created by combining indices of comorbidities
that impact breast cancer survival with age and cancer
stage.
Thus, there are many methodological challenges inherent
in working with older populations. Researchers interested
in studying older women's quality of life will need to be
cognizant of these special issues to ensure high quality
results. Further research is necessary to ensure that we are
using the proper approaches to obtain valid information
and to improve the quality of care for older women.
Future Directions
This review is intended to highlight key outcomes among
older women surviving breast cancer. Our results can be
used to inform clinical decision-making and design inter-
ventions to improve quality of care and optimize func-
tioning in this growing population (Table 2). Additional
research is needed to understand dynamic interactions
between cancer survivorship, comorbidities, aging per se,
poverty, ethnicity, and the processes of interaction with
the medical care system in producing the observed out-
comes of care.
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